Overlooked Stock BHVN

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=fJq0r0xuHG4

Biohaven (BHVN) shares surged after the company's troriluzole drug showed significant slowed progression of spinocerebellar ataxia, a rare neurological disease. George Tsilis shares how the promising results can mark the beginning of a long road to success for Biohaven. • ======== Schwab Network ======== • Empowering every investor and trader, every market day. • • Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe • Download the iOS app - https://apps.apple.com/us/app/schwab-... • Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-... • Watch on Sling - https://watch.sling.com/1/asset/19192... • Watch on Vizio - https://www.vizio.com/en/watchfreeplu... • Watch on DistroTV - https://www.distro.tv/live/schwab-net... • Follow us on X – / schwabnetwork • Follow us on Facebook – / schwabnetwork • Follow us on LinkedIn - / schwab-network • • About Schwab Network - https://schwabnetwork.com/about • #finance #markets #stocks #investing #ataxia #neurologicalhealth #raredisease #medical #biohaven #biology #medical #bhvn #biostock #neuroscience #drug #pharmaceutical #tests #trial

#############################

New on site